Nicholas Tubach
Chief Executive Officer
Nicholas Tubach is a serial biotech entrepreneur. In addition to his
work as the CEO of Propion AKA How to Slow Time, Inc., he is the
cofounder of three pharmaceutical companies developing treatments for
chronic diseases and acute brain damage. Nicholas also studies
Molecular & Cell Biology at UC Berkeley.
Dr. Jan Scicinski
Head of Medicinal Chemistry
Dr Jan Scicinski is an experienced drug discovery and development
scientist, executive, and problem solver with a successful track
record in new pharmaceutical product discovery and development.
He has more than 30 years experience in the pharmaceutical and biotech
industries, in both start-up and large corporate environments (GSK,
Nuada, ALZA, EpicentRx), providing leadership for programs in drug
discovery from hit identification to lead selection and for
development projects including CMC, IND-enabling activities, clinical
trial operations and regulatory filings and communication.
Dr. Scicinski is a Fellow of the Royal Society of Chemistry with
Chartered Chemist Status and holds a PhD from Cambridge University and
BSc hons from Imperial College, London. He has co-authored over 170
peer-reviewed publications, patents, abstracts and book chapters.
Dr. Daniel Winer
Scientific Director
Dr. Daniel Winer is an Associate Professor at the Buck Institute for
Research on Aging with affiliation to the University of Southern
California. He is also an Assistant Professor at the University of
Toronto, Departments of Laboratory Medicine and Pathobiology, and
Immunology, and Affiliate Scientist at the Toronto General Research
Institute.
Dr. Winer is known as an early adopter and promoter of three emerging
fields in science, immunometabolism, mechanoimmunology, and
astroimmunology. Within immunometabolism, Dr. Winer studies how gut
microbiota intersects with the gut immune system to control metabolic
and age related disease. He is the recipient of multiple awards in
this field, including an Amgen Early Investigator Award and a Canada
Research Chair.
Marco Quarta
Strategic Advisor
Dr. Marco Quarta earned a Masters degree in Biotechnology, a PhD in
Neuroscience, and post-doctoral training in Aging and Stem Cells
Biology at Stanford University School of Medicine. He then directed at
Stanford School of Medicine/VA Hospital Palo Alto a research team
focused on translational medical research in the fields of aging and
regenerative medicine.
He is now founder and CEO of Rubedo Life Sciences, driving its mission
to develop treatments for chronic age-related diseases and extend
healthspan, and co-founder of the rejuvenation company, Turn
Biotechnologies, based on his work conducted at Stanford University on
transient epigenetic reprogramming. He additionally sits on the
advisory board of the California Institute for Regenerative Medicine
(CIRM) and research board at the Center for Healthcare Innovation
(CHI).
Dr. Amine Zorgani
Operational Board Member
Amine, is a microbiome expert on a mission to save the human
microbiome from extinction. Leveraging over a decade of research
experience, he is at the forefront of efforts to unlock the potential
of the microbiome.
An engaging speaker at high-profile industry conferences, he shares
his passion for realizing the microbiome’s potential to transform
medicine. Amine’s microbiome posts grab the attention of over 2.6
millions in the past year alone. He leads his team with an infectious
optimism that, together, they can push scientific boundaries. His
mantra is that perseverance and collaboration lead to breakthroughs.
He lends his expertise to international commissions charting the
future of the field such as the Human microbiome action and the
European commission. Driven by scientific rigor and a vision to
improve human health, he is at the vanguard of a new era in microbiome
research and therapeutics.
Maryann Walsh
Operational Board Member
Maryann Walsh is a Registered Dietitian, Certified Personal Trainer,
Certified Diabetes Educator and owner of Walsh Nutrition Consulting
based in Palm Beach, Florida. As a subject matter expert in nutrition
and weight management, Maryann has worked with brands such as
SlimFast, Glanbia Nutritionals, Sprouts Farmers Market, Vitamin Shoppe
and Breyers Ice Cream among others where she provided representation
in publications, copywriting, product and program development as well
as social media content creation.
Scott Fulton
Operational Board Member
Scott Fulton is a change agent at the intersection of aging,
healthspan, and the built environment. An engineer by training,
Fulton’s early corporate research collaborations set the stage for
solving big challenges. Leading change has been a constant across a
divergent career from concept and ideation to scale-up.
A pragmatic systems thinker, his sights are set on raising the
trajectory of US Healthspan and Life Expectancy to world-class. Scott
is President of Home Ideations, President of the National Aging in
Place Council, a member of the American College of Lifestyle Medicine,
and sits on multiple Boards. Fulton also teaches adults on aging at
the Universities of Virginia and Delaware campuses.
He’s a podcast host and author, with his latest book, WHEALTHSPAN™,
due out in early 2024.
Scott Fulton
Operational Board Member
Scott Fulton is a change agent at the intersection of aging,
healthspan, and the built environment. An engineer by training,
Fulton’s early corporate research collaborations set the stage for
solving big challenges. Leading change has been a constant across a
divergent career from concept and ideation to scale-up.
A pragmatic systems thinker, his sights are set on raising the
trajectory of US Healthspan and Life Expectancy to world-class. Scott
is President of Home Ideations, President of the National Aging in
Place Council, a member of the American College of Lifestyle Medicine,
and sits on multiple Boards. Fulton also teaches adults on aging at
the Universities of Virginia and Delaware campuses.
He’s a podcast host and author, with his latest book, WHEALTHSPAN™,
due out in early 2024.
Dr. Bill Andrews
Board of Directors
Scientific Advisory Board
Dr. Bill Andrews is the Founder and CEO of Sierra Sciences, a company
focused on finding ways to extend human lifespan and health span. Bill
received his Ph.D. in Molecular & Population Genetics in 1981 from the
University of Georgia.
Before founding Sierra Sciences Bill was a medical researcher at Armos
Corporation, Codon Corporation, Berlex Biosciences, Geron Corporation,
and EOS Biotech. His research focused on cancer, heart disease,
inflammation, and aging. Bill played key roles in the discoveries of
Human Growth Hormone, Tissue Plasminogen Activator, Osteo-Inductive
Factor, Erythropoietin, Beta-Seron, Telomerase, and Imetelstat, to
name a few.
In 1997 Bill was awarded 2nd Place as National Inventor of the Year
for his cancer research. In the early-to-mid 1990s, while at Geron
Corporation, Bill led the research to discover both the RNA and
protein components of human telomerase, the enzyme responsible for
preventing telomeres from shortening in our reproductive cells.
Presently, the primary focus of Sierra Sciences is to find ways to
produce telomerase and lengthen telomeres in all cells of the human
body.
